469 related items for PubMed ID: 34239607
1. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
2. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
3. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
4. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
Takekoshi N, Kitano N, Takeuchi T, Suenaga T, Kakimoto N, Suzuki T, Kada TT, Shibuta S, Tachibana S, Murayama Y, Yamaga H, Suzuki H.
JAMA Netw Open; 2022 Jun 01; 5(6):e2216642. PubMed ID: 35696166
[Abstract] [Full Text] [Related]
5. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 01; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
6. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 01; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
7. The therapeutic window of intravenous immunoglobulin (IVIG) and its correlation with clinical outcomes in Kawasaki disease: a systematic review and meta-analysis.
Li Z, Cai J, Lu J, Wang M, Yang C, Zeng Z, Tang Q, Li J, Tang W, Luo H, Pan G, Zeng X.
Ital J Pediatr; 2023 Apr 11; 49(1):45. PubMed ID: 37038188
[Abstract] [Full Text] [Related]
8. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
Pediatr Neonatol; 2014 Oct 11; 55(5):387-92. PubMed ID: 24636168
[Abstract] [Full Text] [Related]
9. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Oct 11; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
10. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
[Abstract] [Full Text] [Related]
11. Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.
Liu J, Su D, Yuan P, Ye B, Qin S, Pang Y.
Cardiology; 2023 Sep 27; 148(5):457-468. PubMed ID: 37231847
[Abstract] [Full Text] [Related]
12. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
13. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.
Samadli S, Liu FF, Mammadov G, Wang JJ, Liu HH, Wu YF, Luo HH, Wu Y, Chen WX, Zhang DD, Wei W, Hu P.
Pediatr Rheumatol Online J; 2019 Jul 31; 17(1):53. PubMed ID: 31366406
[Abstract] [Full Text] [Related]
14. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
Lancet Child Adolesc Health; 2018 Dec 31; 2(12):855-862. PubMed ID: 30337183
[Abstract] [Full Text] [Related]
15. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
Wang J, Chen H, Shi H, Zhang X, Shao Y, Hang B, Xu Z, Rong X, Chu M, Qiu H.
Pediatr Rheumatol Online J; 2020 Jun 11; 18(1):48. PubMed ID: 32527316
[Abstract] [Full Text] [Related]
16. The factors affecting the disease course in Kawasaki disease.
Arslanoglu Aydin E, Ertugrul I, Bilginer Y, Batu ED, Sonmez HE, Demir S, Arici ZS, Sag E, Alehan D, Ozen S.
Rheumatol Int; 2019 Aug 11; 39(8):1343-1349. PubMed ID: 31139951
[Abstract] [Full Text] [Related]
17. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar 11; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
18. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics; 2004 Dec 11; 114(6):e689-93. PubMed ID: 15545617
[Abstract] [Full Text] [Related]
19. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, Takahashi K, Okada S, Wakiguchi H, Moriwake T, Uchida M, Ohbuchi N, Iwai T, Hasegawa M, Ichihara K, Yashiro M, Makino N, Nakamura Y, Ohga S.
Int J Cardiol; 2016 Jul 01; 214():209-15. PubMed ID: 27070994
[Abstract] [Full Text] [Related]
20. Therapeutic Window of Intravenous Immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki Disease: a retrospective study.
Cai JH, Tang M, Zhang HX, Dan Luo E, Zhang R, Shuai SP, Liang H, Tao WJ, Wu MJ, Wen Y, Yang YF.
J Pediatr (Rio J); 2023 Jul 01; 99(2):161-167. PubMed ID: 35995125
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
